CHOC researchers seek to study the role of Tregs in whether pediatric leukemia patients treated with CAR T-cell therapy experience a relapse.
CHOC is pioneering surgical approaches to patellofemoral instability and patellar dislocation, as well as postsurgical pain mitigation.
The recent PEDS2040 conference brought together medical staff and leaders to collaborate on innovation in pediatric healthcare.
A CHOC expert discusses the frequency and risk of diagnostic errors in pediatric medicine, and discusses processes to prevent them.
Student intern with the CHOC Research Institute gets valuable experience from working on research studies and shadowing surgeons.
The CHOC Research Institute aims to pave the way for innovation in pediatric treatments with strategic academic partnerships.